Price v. United States Of America

CourtDistrict Court, S.D. Ohio
DecidedJanuary 16, 2020
Docket2:18-cv-00949
StatusUnknown

This text of Price v. United States Of America (Price v. United States Of America) is published on Counsel Stack Legal Research, covering District Court, S.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Price v. United States Of America, (S.D. Ohio 2020).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF OHIO EASTERN DIVISION

Raymond Price,

Plaintiff, Case No. 2:18-cv-949

v. Judge Sarah D. Morrison Magistrate Judge Chelsey M. Vascura United States of America, et al.,

Defendants.

OPINION AND ORDER This matter is before the Court on a Motion for Summary Judgment filed by Defendant Ambulatory Care Solutions of Ohio, LLC.1 (ECF No. 31.) Plaintiff filed a Memorandum in Opposition to the Motion (ECF No. 33), and Defendant filed a Reply (ECF No. 41). The matter is now ripe for decision. I. STATEMENT OF THE FACTS Plaintiff Raymond Price, a veteran, is a patient of the Department of Veterans Affairs (“VA”) Medical Center in Belmont County, Ohio (the “VA-Belmont”). (Amended Compl. ¶ 35, ECF No. 25.) The VA-Belmont is a part of the VA-Pittsburgh Health System (“VAPHS”). (Id. ¶¶ 2–3.) In March 2015, the VA entered into a contract with Ambulatory Care Solutions, LLC, (“ACS”) to provide primary care services at the VA-Belmont (the “Contract”). (U.S. Mot. Dismiss Ex. A, ECF No. 27-1, at 1, 9–10.) At some point, ACS formed Defendant Ambulatory Care Solutions of Ohio, LLC, (“ACS of Ohio”) to fulfill these contractual obligations and to

1 Plaintiff’s Amended Complaint names Ambulatory Care Solutions, LLC, as a defendant. (ECF No. 25, at 1–2.) Ambulatory Care Solutions of Ohio, LLC, filed an Answer, contending that it is the proper defendant and was misidentified as Ambulatory Care Solutions, LLC, in the Amended Complaint. (ECF No. 26.) On January 3, 2020, the parties filed a status report stipulating that Ambulatory Care Solutions of Ohio, LLC, is the appropriate defendant and should be substituted as such. (ECF No. 51.) operate the VA-Belmont. (ECF No. 51, ¶ 2.) During the relevant time period, until at least November 2016, the providers at the VA-Belmont were employed by ACS of Ohio. (Christina Hood Aff. ¶ 4, ECF No. 31-1.) Pursuant to this Contract, ACS was responsible for “comply[ing] with all relevant VA

policies and procedures, including those related to quality, patient safety and performance . . . .” (ECF No. 27-1, at 7.) These policies and procedures included VHA Directive 2009-019 and VHA Directive 1088 (collectively, the “Directives”), which govern the transmission of results for diagnostic tests at VA clinics. (Amended Compl. Exs. 2, 4, ECF Nos. 25-2, 25-4.) Mr. Price has been a patient of the VA-Belmont for several years. (Pl. Opp. to Def. Mot. for Summ. J. Ex. 8, ECF No. 33-9.) He has gone to the VA-Belmont for his routine annual lab work, and he plans to continue to do so. (Id.) As a part of his annual lab work, the VA-Belmont tests Mr. Price’s Prostate-Specific Antigen (“PSA”) levels because of his family history of cancer. (ECF No. 25 ¶¶ 36–37.) PSA is a protein produced by the prostate, and elevated levels of PSA (above four ng/ml) indicate a risk of prostate cancer. (Id. ¶¶ 37–38.)

On October 2, 2015, Mr. Price had blood drawn at the VA-Belmont, and a nurse practitioner sent his blood to the VAPHS laboratory for testing, including a PSA test. (Id. ¶¶ 40, 43, 44.) Mr. Price left the VA-Belmont without receiving the results of his PSA test. (Id. ¶¶ 41– 42.) VAPHS completed the PSA test later that same day and, at some point, notated in Mr. Price’s medical record that he had an elevated PSA level of 61.98 ng/ml. (Id. ¶¶ 42, 44.) On October 9, 2015, VAPHS sent Mr. Price’s October 2, 2015, blood test results to his regular primary care provider, who works outside of the VA system. (Id. ¶ 48; Amended Compl. Ex. 5, ECF No. 25-5.) This transmission did not include the results of the PSA test. (ECF No. 25 ¶ 49.) Over one year later, on October 28, 2016, Mr. Price returned to the VA-Belmont for another PSA test. (Id. ¶ 54.) This test showed that Mr. Price’s PSA level had further increased to 145.36 ng/ml. (Id.) On November 16, 2016, Mr. Price visited the VA-Belmont where he learned for the first time that his PSA levels were elevated. (Id. ¶¶ 55, 58.)

Shortly after Mr. Price learned this information, he sought treatment from an oncologist, Dr. Gregory Merrick, at Wheeling Hospital. (Id. ¶ 60.) On December 13, 2016, Dr. Merrick diagnosed Mr. Price with advanced prostate cancer. (Id. ¶¶ 60, 63) According to Dr. Russell Pachynski, another oncologist, Mr. Price’s prostate cancer “progress[ed] and spread to a substantial and significant degree” between the time of the October 2, 2015, PSA test and the October 28, 2016, test. (Amended Compl. Ex. 7, ECF No. 25-7 ¶ 6.) On November 15, 2017, Mr. Price submitted an administrative claim of medical malpractice to the VA. (ECF No. 25 ¶ 66.) On June 13, 2018, the VA denied Mr. Price’s claim on the grounds that the relevant VA-Belmont employees were contract employees2, precluding liability for the United States. (U.S. Mot. Dismiss Ex. B, ECF No. 27-2.) Mr. Price contends that

he did not, and could not have known with the exercise of reasonable diligence, that the providers at the VA-Belmont were employed by ACS.3 (ECF No. 25 ¶ 76.) He contends that the VA-Belmont providers never told him that they were employed by ACS, that he always believed he was receiving care from the VA, and that he never knew about the existence of ACS until receiving the VA’s June 13 letter. (Raymond Price Aff. ¶¶ 3–6, ECF No. 25-6.)

2 In its letter, the VA identified its contractor as ACS. (ECF No. 27-2.) There is no mention in the letter of the existence of ACS of Ohio.

3 Mr. Price’s Amended Complaint references ACS rather than ACS of Ohio. The Court assumes for purposes of this motion that Mr. Price’s assertions about ACS apply in equal measure to Defendant ACS of Ohio. On August 23, 2018, Mr. Price filed a Complaint against the United States and against ACS. (Compl., ECF No. 1.) On March 7, 2019, Mr. Price filed an Amended Complaint. (ECF No. 25.) The Amended Complaint pleads allegations of negligence against ACS (Count One) and the United States (Counts Two and Three). (Id. at 21–28.) The parties have since agreed to

substitute ACS of Ohio for ACS as the appropriate defendant. (ECF No. 51.) II. STANDARD OF REVIEW Summary judgment is appropriate when “there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(a). The movant has the burden of establishing there are no genuine issues of material fact, which may be achieved by demonstrating the nonmoving party lacks evidence to support an essential element of its claim. Celotex Corp. v. Catrett, 477 U.S. 317, 322–23 (1986); Barnhart v. Pickrel, Schaeffer & Ebeling Co., 12 F.3d 1382, 1388–89 (6th Cir.1993). The burden then shifts to the nonmoving party to “‘set forth specific facts showing that there is a genuine issue for trial.’” Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 250 (1986) (quoting Fed. R. Civ. P. 56). When

evaluating a motion for summary judgment, the evidence must be viewed in the light most favorable to the non-moving party. Adickes v. S.H. Kress & Co., 398 U.S. 144, 158–59 (1970). A genuine issue exists if the nonmoving party can present “significant probative evidence” to show that “there is [more than] some metaphysical doubt as to the material facts.” Moore v. Philip Morris Cos., 8 F.3d 335, 339–40 (6th Cir. 1993). In other words, “summary judgment will not lie .

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Adickes v. S. H. Kress & Co.
398 U.S. 144 (Supreme Court, 1970)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
John M. Atkins v. Union Pacific Railroad Company
753 F.2d 776 (Ninth Circuit, 1985)
Stanley v. Sewell Coal Co.
285 S.E.2d 679 (West Virginia Supreme Court, 1982)
Natl. Union Fire Ins. Co. of Pittsburgh, PA v. Wuerth
2009 Ohio 3601 (Ohio Supreme Court, 2009)
Livingston v. Diocese of Cleveland
710 N.E.2d 330 (Ohio Court of Appeals, 1998)
Grubb v. Columbus Community Hospital
691 N.E.2d 333 (Ohio Court of Appeals, 1997)
Amadasu v. O'Neal
891 N.E.2d 802 (Ohio Court of Appeals, 2008)
Textron Financial Corp. v. Nationwide Mutual Insurance
684 N.E.2d 1261 (Ohio Court of Appeals, 1996)
Balascoe v. St. Elizabeth Hospital Medical Center
673 N.E.2d 651 (Ohio Court of Appeals, 1996)
Cerney v. Norfolk & Western Railway Co.
662 N.E.2d 827 (Ohio Court of Appeals, 1995)
Hill v. Wadsworth-Rittman Area Hospital
925 N.E.2d 1012 (Ohio Court of Appeals, 2009)
Tisdale v. Toledo Hospital
967 N.E.2d 280 (Ohio Court of Appeals, 2012)
Gelbman v. Second National Bank
458 N.E.2d 1262 (Ohio Supreme Court, 1984)
Nickell v. Gonzalez
477 N.E.2d 1145 (Ohio Supreme Court, 1985)
Cohen v. Estate of Cohen
491 N.E.2d 698 (Ohio Supreme Court, 1986)
Frysinger v. Leech
512 N.E.2d 337 (Ohio Supreme Court, 1987)

Cite This Page — Counsel Stack

Bluebook (online)
Price v. United States Of America, Counsel Stack Legal Research, https://law.counselstack.com/opinion/price-v-united-states-of-america-ohsd-2020.